http://www.mail.com/subjects/984726-osteoporosis.html Mail.com - the best personalized free web-based Email en en http://sec-s.uicdn.com/mail.com/2.28/img/mailcom_logo_rss.png http://www.mail.com/subjects/984726-osteoporosis.html http://www.mail.com/scitech/health/1933894-fda-panel-sees-risk-long-used-osteoporosis-drug.html WASHINGTON (AP) — A panel of federal health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer. The Food and Drug Administration panel voted 12-9 that the risks of the inhalable osteoporosis drug outweigh its benefits when used ... Tue, 05 Mar 2013 22:53:43 GMT http://www.mail.com/scitech/health/1933894-fda-panel-sees-risk-long-used-osteoporosis-drug.html 2013-03-05T22:53:43Z http://www.mail.com/business/economy/1861592-generic-competition-charges-cut-merck-q4-profit.html Merck & Co.'s fourth-quarter profit fell 7 percent because of hits from generic competition and one-time charges, and the company pushed back plans for seeking approval of a key experimental osteoporosis drug. The quarterly results beat Wall Street expectations, but Merck shares fell Friday as investors learned the company is reviewing safety and efficacy... Fri, 01 Feb 2013 20:09:00 GMT http://www.mail.com/business/economy/1861592-generic-competition-charges-cut-merck-q4-profit.html 2013-02-01T20:09:00Z